genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab
News
Takeda Licenses COUR’s Celiac Disease Candidate after Successful Phase IIa Trial
Cell Analysis
Cell Stiffness May Indicate Likelihood of Cancer Metastasis
News
Creatine Arms T Cells for the Battle against Cancer
Artificial Intelligence
Synthetic Biologists Develop an Ear for the Language of Proteins
Insights
Insights
Top 10 Asia Biopharma Clusters 2019
Tech Exclusives
Genome Editing Heads to Primetime
On Your Radar
From Poetry to Policy: An Interview with Bartha Maria Knoppers
Commentary
Successfully Addressing the Challenges of Glycosylation
Brexit
Top 10 European Biopharma Clusters
A-Lists
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
Insights
Top 10 U.S. Biopharma Clusters
Insights
10 Takeover Targets to Watch This Fall
Insights
What the Top 10 Biopharma CEOs Are Making
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab
Bioprocessing
Process Guidance: Cellvento® 4CHO Fed-batch Medium
News
Takeda Licenses COUR’s Celiac Disease Candidate after Successful Phase IIa Trial
Cell Analysis
Cell Stiffness May Indicate Likelihood of Cancer Metastasis
Magazine
All
Supplement
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
October 2019 Vol. 39 No. 10
CRISPR Dx May Help Nix Disease
Tech Exclusives
Modular Bioprocessing Makes Adaptability a Snap
Tech Exclusives
A Nanomedicine Technology Sampler Pack
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
Vaccinating the World One Collaboration at a Time
eBooks
Better Research Begins with an Experienced Solution Provider
Upcoming Webinars
A Cultured Life: Innovations in Spheroid and Organoid Models
Posters
Microfluidic Diffusional Sizing: A Novel Method for Characterizing Protein Interactions
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
Amgen
Amgen
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Amgen
Amgen Eyes Inflammatory Disease Expansion with Planned $13.4B Purchase of Celgene’s Otezla
Amgen
Amgen Offers $167M for Cancer Collaboration Partner Nuevolution
Amgen
Amgen, Entera to Partner on Oral Drugs for Inflammatory Disease, Other “Serious” Illnesses
Amgen
Amgen Selects Second Cancer Target in 2-Year-Old Collaboration with Nuevolution
Amgen
Amgen, MD Anderson Launch Two Cancer Collaborations
Amgen
Amgen, Novartis Set to Launch Migraine Drug Aimovig Next Week after...
Amgen
Federal Circuit Favors Novartis’ Sandoz over Amgen in Biosimilar “Patent Dance”...
Amgen
Amgen, Novartis Expand Alzheimer’s Collaboration with New Trial
Amgen
Amgen, CytomX Launch Up-to-$1.465B+ Cancer Immunotherapy Collaboration
Amgen
Amgen Delaying U.S. Launch of Humira Biosimilar in Settlement with AbbVie
Amgen
After FDA Approval, Amgen–Allergan Cancer Biosimilar Mvasi Faces Launch, Pricing Challenges
Amgen
FDA to Review BLA for Amgen-Novartis Migraine Prevention Treatment
Amgen
Amgen Licenses Ligand’s Captisol Technology for AML Candidate AMG 330
Amgen
FDA Rejects Amgen-UCB Osteoporosis Candidate Evenity
Amgen
EC Clears Sandoz’s Erelzi Biosimilar Etanercept Copy of Amgen’s Enbrel
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
